Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and highly protective in a ring vaccination trial. We aimed to identify transcriptomic immune response biomarker signatures induc...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Vianello, E, Gonzalez-Dias, P, van Veen, S, Engele, CG, Quinten, E, Monath, TP, Medaglini, D, Agnandij, ST, Ahmed, R, Anderson, J, Auderset, F, Bejon, P, Borgianni, L, Brosnahan, J, Ciabattini, A, Engler, O, Haks, MC, Harandi, AM, Heppner, DG, Gerlini, A, Huttner, A, Kremsner, PG, Ndungu, FM, Njuguna, P, Ottenhoff, THM, Pejoski, D, Page, M, Pozzi, G, Santoro, F, Siegrist, CA, Dubey, S, Eichberg, M, Ndong, EP, Lumeka, K, Nakaya, HI, Gonzales Dias Carvalho, P, Rothenberger, S, Nakka, SS, Essone, PN, Agnandji, ST
التنسيق:	Journal article
اللغة:	English
منشور في:	Elsevier 2021

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study

مواد مشابهة